<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR1">
 <label>1.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mizokami</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Yokosuka</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Takehara</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Sakamoto</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Korenaga</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Mochizuki</surname>
    <given-names>H</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial</article-title>
  <source>Lancet Infect Dis</source>
  <year>2015</year>
  <volume>15</volume>
  <fpage>645</fpage>
  <lpage>653</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(15)70099-X</pub-id>
  <pub-id pub-id-type="pmid">25863559</pub-id>
 </element-citation>
</ref>
